Albert Di Rienzo to attend the Second Annual Regional Biotech Forum as both President & CEO of Radicle Innovation as well as a member of the Angel Capital Association Life Sciences Group

There are many regional biotechnology clusters within the United States, with some of the more familiar ones being San Francisco, Boston / Cambridge, San Diego, and Raleigh-Durham.  One of the more prominent, yet perhaps less familiar regions is the Maryland / Washington, DC / Northern, Virginia biotech cluster, with over 800 life sciences companies, over 70 federal labs, and multiple preeminent academic institutions, such as Johns Hopkins University – a longtime national leader in research grant funding.  This biotech cluster is a regional economic development engine, accounting for approximately 25% of all job growth, including such entities as the National Institute of Health, AstraZeneca and GlaxoSmithKline.

The Second Annual Regional BioTech Forum will be hosted by MedImmune at One Medimmune Way in Gaithersburg, MD, on the 18th and 19th of April. The Forum will highlight biotechnology advances, the role of certain government agencies and others in promoting collaboration, funding options, workforce development, ecosystem convergence, and much more.  Post Forum, Di Rienzo will report highlights to Radicle Innovation, key collaborators, and the Angel Capital Association Life Sciences Group.

For more information on the Second Annual Regional BioTech Forum, please visit